Elite Pharmaceuticals Inc (ELTP)

[Sixman]

I have chastised no one. Quite the contrary. Following the P3 PR, this stock traded into mid 40s. It crashed to the high 20s at the conference call that followed. It's based out in the mid to low 30s since. This basing has occurred even with some major news. NDA for ELi200 filed, NDA filing fee waiver (standard FDA practice BTW), NDA application accepted and given priority review. So yea, a return to the mid 40s is a minor bump.

IF news of approval causes a breakout with volume and higher highs, THEN maybe this thing will start getting exciting.

Refusing to accept an overly rosy and optimistic outcome is hardly negative, nor is it bashing. Too many on this board pounce on those that provide any opinion that's contrary to the millionaire maker mentality. It's a market, people have different perspectives and viewpoints.

Time will prove which side is more correct.